BIOCORP Obtains 510(k) FDA Clearance for Mallya®

Already CE marked, the FDA’s authorization reinforces BIOCORP’s technological leadership in the smart pens market. Supported…

Everbridge Unveils PSInsights, an Industry-Leading Public Safety Solution With Real-Time Situational Awareness for Accelerated Emergency Response

Everbridge PSInsights™, part of the company’s Public Safety solution, provides public authorities with real-time visibility and…

JPIX partners With Cisco and Qwilt to Advance Streaming Media Delivery Across Japan

News Summary JPIX, one of Japan’s largest internet exchanges, joins forces with Cisco and Qwilt to…

Trellix Predicts Heightened Hacktivism and Geopolitical Cyberattacks in 2023

SAN JOSE, Calif.–(BUSINESS WIRE)–Trellix, the cybersecurity company delivering the future of extended detection and response (XDR),…

KKR to acquire Clinisupplies to accelerate growth and help build a leading international chronic care medical devices platform

KKR to support organic and inorganic growth to enhance Clinisupplies’ leadership position in collecting devices and…

FREYR Battery and Nidec Corporation Complete Formation of Joint Venture

NEW YORK & OSLO, Norway & LUXEMBOURG–(BUSINESS WIRE)–FREYR Battery (NYSE: FREY) (“FREYR”), a developer of clean,…

BEX Mauritius Block Exchange Receives the World’s First Ever Security Token Trading License from the Financial Services Commission (FSC) Mauritius

EBÈNE CITY, Mauritius–(BUSINESS WIRE)–BEX Mauritius Block Exchange (“BEX”) announced today that the Financial Services Commission (“FSC”)…

Sweden Achieves the Lowest Smoking Rate in Europe and is on Track to Become Officially Smoke-Free – The EU Must Take Note

STOCKHOLM–(BUSINESS WIRE)–Swedish authorities officially confirmed that the current level of smoking in Sweden has fallen to…

TNS Launches Market Data Services for Tel Aviv Stock Exchange

Continuing the expansion of TNS’ global trading network RESTON, Va.–(BUSINESS WIRE)–#colocation—Transaction Network Services (TNS) is now…

LEO Pharma Announces Positive Phase 3 Topline Results From DELTA 1 Trial With Delgocitinib Cream in Adults With Moderate to Severe Chronic Hand Eczema (CHE)

The first phase 3 clinical trial (DELTA 1) with delgocitinib cream in adults with moderate to…